This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
United Kingdom, London
[email protected] is the renowned Corporate Investor, which was created in 2014. The fund is located in United Kingdom, Europe. The main office of this Corporate Investor is situated in London.
Among their most successful investment fields, we have identified Medical, Internet. Also, because of its portfolio diversification tendency, we can highlight 15 more industries for this fund. Also, a start-up has to be aged 2-3 years to expect investment from this fund. The fund has no an exact preference in the amount of founders of companies in its portfolio. If there are 5+ founders in the start-up, the probability of getting the investment is low. WaveOptics, Healx, Yoyo Wallet are amongst the various portfolio companies of this fund. The country of its foundation and the country of its most frequent investments coincides - United Kingdom. Besides this, the fund also invested in 4 other countries.
The fund usually invests in rounds together with 1-2 others. Aside from [email protected], start-ups are often funded by Techstars, Seedrs, Northstar Ventures and 68 other funds. Other VCs who often invest in the same rounds are Microsoft Accelerator London, MassChallenge, Theo Osborne. In subsequent rounds, the fund is usually supported by Upscale, Techstart Ventures, MassChallenge, out of 92 investors from our database.
At the time of investment by [email protected], a typical start-up valuation would be 1-5 millions dollars. Typical investments for this fund are deals in the range of 100 thousands - 1 million dollars. [email protected] participates, on average, in 26 percentage points less than the average amount of lead investments in other funds. The fund typically enters into more than 49 deals annually. The highest number of exits from this fund were in 2019. The fund's activity peaked in 2016. In addition, the fund was active in 2019. In terms of the fund's performance, this Corporate Investor has 14 percentage points less exits when compared to other organizations.
Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]
Domain name: royal.uk; User name format in descending order of probability: first '.' last
Group Appearance [how often fund is operating separately from groups with shared interest]
97.2% of cases
Investments per Year [average amount of rounds in which fund participates each year]
Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]
0.7% of cases
Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]
Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]
Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]
0.2 out of 1
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.